An Open-Label Study to Evaluate the Safety of NP101 in the Treatment of Acute Migraine Over Twelve Months
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Mark Pierce, M.D., PhD.
NuPathe Inc.
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
31 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Facility name not stated
Phoenix, Arizona, United States
- Facility name not stated
Scottsdale, Arizona, United States
- Facility name not stated
Irvine, California, United States
- Facility name not stated
Newport Beach, California, United States
- Facility name not stated
San Francisco, California, United States
- Facility name not stated
Santa Monica, California, United States
- Facility name not stated
Walnut Creek, California, United States
- Facility name not stated
Fairfield, Connecticut, United States
- Facility name not stated
Hallandale, Florida, United States
- Facility name not stated
Ocala, Florida, United States
- Facility name not stated
Sunrise, Florida, United States
- Facility name not stated
Atlanta, Georgia, United States
- Facility name not stated
Decatur, Georgia, United States
- Facility name not stated
Savannah, Georgia, United States
- Facility name not stated
Crestview Hills, Kentucky, United States
- Facility name not stated
Ann Arbor, Michigan, United States
- Facility name not stated
St Louis, Missouri, United States
- Facility name not stated
Mount Vernon, New York, United States
- Facility name not stated
Plainview, New York, United States
- Facility name not stated
Greensboro, North Carolina, United States
- Facility name not stated
Cincinnati, Ohio, United States
- Facility name not stated
Cleveland, Ohio, United States
- Facility name not stated
Oklahoma City, Oklahoma, United States
- Facility name not stated
Philadelphia, Pennsylvania, United States
- Facility name not stated
Pittsburgh, Pennsylvania, United States
- Facility name not stated
Clarksville, Tennessee, United States
- Facility name not stated
Dallas, Texas, United States
- Facility name not stated
San Antonio, Texas, United States
- Facility name not stated
Alexandria, Virginia, United States
- Facility name not stated
Virginia Beach, Virginia, United States
- Facility name not stated
Seattle, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 28 Feb 2009
- Primary completion
- 31 May 2011
- Completion
- 31 May 2011
- Last update posted
- 4 Feb 2016
- Registered enrollment
- 514
- Registry id
- NCT00806546
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.